Journal of General Virology, Vol 79, 1215-1224, Copyright © 1998 by Society for General Microbiology

ARTICLES

Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies

JA Liljeqvist, E Trybala, B Svennerholm, S Jeansson, E Sjogren-Jansson and T Bergstrom
Department of Virology, Goteborg University, Sweden. liljeja@clavicula.mednet.gu.se

Glycoprotein G is a major target for the humoral immune response against herpes simplex virus (HSV) and a prototype antigen for type- specific serodiagnosis discriminating HSV-1 and HSV-2 infections. The mature part of HSV-2 glycoprotein G-2 (gG-2) contains a unique stretch suspected to mediate type specificity, and in addition a region homologous to HSV-1 glycoprotein G-1 (gG-1). Antigenic determinants of the mature gG-2 were mapped by testing the reactivity of mouse anti-gG- 2 monoclonal antibodies (MAbs) and purified human anti-gG-2 antibodies with synthetic peptides coupled to cellulose membranes. The anti-gG-2 MAbs bound to four epitopes localized in a narrow cluster within a gG-2 segment delimited by amino acids (aa) 552 and 611. This cluster was located between the predicted O-glycan-rich region and the transmembrane anchor sequence. The epitopes of the human anti-gG-2 antibodies were localized within three stretches of amino acids, two of which were overlapping with those recognized by anti-gG-2 MAbs. One of these stretches, delimited by aa 552 and 574, showed reactivity to all human HSV-2 sera tested, but not to HSV-1 sera or to purified anti-gG-1 antibodies. Neither the anti-gG-2 MAbs nor the purified human anti-gG-2 antibodies were cross-reactive to gG-1 peptides or HSV-1 antigen, although most of the epitopes were localized within the part of gG-2 which was homologous to gG-1. The findings concerning HSV-2 type- specific human antibody response to a defined stretch within gG-2 may be of importance for the further development of type-discriminating serodiagnosis.

This article has been cited by other articles:

				S. Gorander, T. Lagergard, M. Romanik, R. P. Viscidi, G. Martirosian, and J.-A. Liljeqvist Seroprevalences of Herpes Simplex Virus Type 2, Five Oncogenic Human Papillomaviruses, and Chlamydia trachomatis in Katowice, Poland Clin. Vaccine Immunol., April 1, 2008; 15(4): 675 - 680. [Abstract] [Full Text] [PDF]

				A. Fujima, Y. Ochiai, A. Saito, Y. Omori, A. Noda, Y. Kazuyama, H. Shoji, K. Tanabayashi, F. Ueda, Y. Yoshikawa, et al. Discrimination of Antibody to Herpes B Virus from Antibody to Herpes Simplex Virus Types 1 and 2 in Human and Macaque Sera J. Clin. Microbiol., January 1, 2008; 46(1): 56 - 61. [Abstract] [Full Text] [PDF]

				M. J. Kasubi, A. Nilsen, H. S. Marsden, T. Bergstrom, N. Langeland, and L. Haarr Prevalence of Antibodies against Herpes Simplex Virus Types 1 and 2 in Children and Young People in an Urban Region in Tanzania. J. Clin. Microbiol., August 1, 2006; 44(8): 2801 - 2807. [Abstract] [Full Text] [PDF]

				S. Gorander, J. Mbwana, E. Lyamuya, T. Lagergard, and J.-A. Liljeqvist Mature Glycoprotein G Presents High Performance in Diagnosing Herpes Simplex Virus Type 2 Infection in Sera of Different Tanzanian Cohorts Clin. Vaccine Immunol., June 1, 2006; 13(6): 633 - 639. [Abstract] [Full Text] [PDF]

				L. Perelygina, I. Patrusheva, S. Hombaiah, H. Zurkuhlen, M. J. Wildes, N. Patrushev, and J. Hilliard Production of Herpes B Virus Recombinant Glycoproteins and Evaluation of Their Diagnostic Potential J. Clin. Microbiol., February 1, 2005; 43(2): 620 - 628. [Abstract] [Full Text] [PDF]

				P. Tunback, T. Bergstrom, G.-B. Lowhagen, J. Hoebeke, and J.-A. Liljeqvist Type-specific reactivity of anti-glycoprotein G antibodies from herpes simplex virus-infected individuals is maintained by single or dual type-specific residues J. Gen. Virol., February 1, 2005; 86(2): 247 - 251. [Abstract] [Full Text] [PDF]

				K. Eriksson, L. Bellner, S. Gorander, G.-B. Lowhagen, P. Tunback, K. Rydberg, and J.-A. Liljeqvist CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals J. Gen. Virol., August 1, 2004; 85(8): 2139 - 2147. [Abstract] [Full Text] [PDF]

				F. Bugli, S. Manzara, R. Torelli, R. Graffeo, R. Santangelo, P. Cattani, and G. Fadda Human Monoclonal Antibody Fragment Specific for Glycoprotein G in Herpes Simplex Virus Type 2 with Applications for Serotype-Specific Diagnosis J. Clin. Microbiol., March 1, 2004; 42(3): 1250 - 1253. [Abstract] [Full Text] [PDF]

				S. Q. Wales, C. C. Smith, M. Wachsman, G. Calton, and L. Aurelian Performance and Use of a Ribonucleotide Reductase Herpes Simplex Virus Type-Specific Serological Assay Clin. Vaccine Immunol., January 1, 2004; 11(1): 42 - 49. [Abstract] [Full Text] [PDF]

				S. Gorander, B. Svennerholm, and J.-A. Liljeqvist Secreted Portion of Glycoprotein G of Herpes Simplex Virus Type 2 Is a Novel Antigen for Type-Discriminating Serology J. Clin. Microbiol., August 1, 2003; 41(8): 3681 - 3686. [Abstract] [Full Text] [PDF]

				E. Rekabdar, P. Tunback, J.-A. Liljeqvist, M. Lindh, and T. Bergstrom Dichotomy of Glycoprotein G Gene in Herpes Simplex Virus Type 1 Isolates J. Clin. Microbiol., September 1, 2002; 40(9): 3245 - 3251. [Abstract] [Full Text] [PDF]

				M. Ikoma, J.-A. Liljeqvist, J. Groen, K. L. Glazenburg, T. H. The, and S. Welling-Wester Use of a Fragment of Glycoprotein G-2 Produced in the Baculovirus Expression System for Detecting Herpes Simplex Virus Type 2-Specific Antibodies J. Clin. Microbiol., July 1, 2002; 40(7): 2526 - 2532. [Abstract] [Full Text] [PDF]

				B. R. Eing, L. Lippelt, E. U. Lorentzen, W. Hafezi, W. Schlumberger, K. Steinhagen, and J. E. Kuhn Evaluation of Confirmatory Strategies for Detection of Type-Specific Antibodies against Herpes Simplex Virus Type 2 J. Clin. Microbiol., February 1, 2002; 40(2): 407 - 413. [Abstract] [Full Text] [PDF]

				J.-A. Liljeqvist, E. Trybala, J. Hoebeke, B. Svennerholm, and T. Bergstrom Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants J. Gen. Virol., January 1, 2002; 83(1): 157 - 165. [Abstract] [Full Text] [PDF]

				J.-A. Liljeqvist, B. Svennerholm, and T. Bergström Conservation of Type-Specific B-Cell Epitopes of Glycoprotein G in Clinical Herpes Simplex Virus Type 2 Isolates J. Clin. Microbiol., December 1, 2000; 38(12): 4517 - 4522. [Abstract] [Full Text]

				P. Tunbäck, J.-A. Liljeqvist, G.-B. Löwhagen, and T. Bergström Glycoprotein G of herpes simplex virus type 1: identification of type-specific epitopes by human antibodies J. Gen. Virol., April 1, 2000; 81(4): 1033 - 1040. [Abstract] [Full Text]

				J.-A. Liljeqvist, B. Svennerholm, and T. Bergström Herpes Simplex Virus Type 2 Glycoprotein G-Negative Clinical Isolates Are Generated by Single Frameshift Mutations J. Virol., December 1, 1999; 73(12): 9796 - 9802. [Abstract] [Full Text]

				E. Rekabdar, P. Tunback, J.-A. Liljeqvist, and T. Bergstrom Variability of the Glycoprotein G Gene in Clinical Isolates of Herpes Simplex Virus Type 1 Clin. Vaccine Immunol., November 1, 1999; 6(6): 826 - 831. [Abstract] [Full Text] [PDF]

				J.-A. Liljeqvist, B. Svennerholm, and T. Bergström Typing of Clinical Herpes Simplex Virus Type 1 and Type 2 Isolates with Monoclonal Antibodies J. Clin. Microbiol., August 1, 1999; 37(8): 2717 - 2718. [Abstract] [Full Text]

				R. L. Ashley, M. Eagleton, and N. Pfeiffer Ability of a Rapid Serology Test To Detect Seroconversion to Herpes Simplex Virus Type 2 Glycoprotein G Soon after Infection J. Clin. Microbiol., May 1, 1999; 37(5): 1632 - 1633. [Abstract] [Full Text]